Product
Isoniazid and Rifapentine
2 clinical trials
3 indications
Indication
Latent Tuberculosis InfectionIndication
Diabetes MellitusIndication
TuberculosisClinical trial
Comparing Incidence Rate of Systemic Drug Reactions Under 3HP and 1HP Regimen for Latent Tuberculosis Infection Treatment: a Pragmatic Multicenter Randomized Control TrialStatus: Completed, Estimated PCD: 2023-10-08
Clinical trial
A Randomized Double Blind Placebo Controlled Trial of Rifapentine and Isoniazid for Prevention of Tuberculosis in People With DiabetesStatus: Recruiting, Estimated PCD: 2025-12-01